NCT02128906 2026-04-16
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
Phase 2 Recruiting
University of Pittsburgh
National Cancer Institute (NCI)
Royal Marsden NHS Foundation Trust
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company
M.D. Anderson Cancer Center